NM_000535.7(PMS2):c.276T>G (p.Ile92Met) AND Hereditary nonpolyposis colorectal neoplasms

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Nov 10, 2022
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003760853.2

Allele description [Variation Report for NM_000535.7(PMS2):c.276T>G (p.Ile92Met)]

NM_000535.7(PMS2):c.276T>G (p.Ile92Met)

Gene:

PMS2:PMS1 homolog 2, mismatch repair system component [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

7p22.1

Genomic location:

Preferred name:

NM_000535.7(PMS2):c.276T>G (p.Ile92Met)

HGVS:

NC_000007.14:g.6003767A>C
NG_008466.1:g.10340T>G
NM_000535.7:c.276T>GMANE SELECT
NM_001018040.1:c.-130T>G
NM_001322003.2:c.-130T>G
NM_001322004.2:c.-130T>G
NM_001322005.2:c.-130T>G
NM_001322006.2:c.276T>G
NM_001322007.2:c.35+205T>G
NM_001322008.2:c.35+205T>G
NM_001322009.2:c.-130T>G
NM_001322010.2:c.-130T>G
NM_001322011.2:c.-609T>G
NM_001322012.2:c.-609T>G
NM_001322013.2:c.-130T>G
NM_001322014.2:c.276T>G
NM_001322015.2:c.-209T>G
NM_001406866.1:c.462T>G
NM_001406868.1:c.300T>G
NM_001406869.1:c.276T>G
NM_001406870.1:c.276T>G
NM_001406871.1:c.276T>G
NM_001406872.1:c.276T>G
NM_001406873.1:c.276T>G
NM_001406874.1:c.276T>G
NM_001406875.1:c.-209T>G
NM_001406876.1:c.35+205T>G
NM_001406877.1:c.-209T>G
NM_001406878.1:c.-209T>G
NM_001406879.1:c.-209T>G
NM_001406880.1:c.-156T>G
NM_001406881.1:c.-132+205T>G
NM_001406882.1:c.-209T>G
NM_001406883.1:c.35+205T>G
NM_001406884.1:c.276T>G
NM_001406885.1:c.250+205T>G
NM_001406886.1:c.276T>G
NM_001406887.1:c.-130T>G
NM_001406888.1:c.-77T>G
NM_001406889.1:c.-77T>G
NM_001406890.1:c.-120T>G
NM_001406891.1:c.-130T>G
NM_001406892.1:c.-77T>G
NM_001406893.1:c.-130T>G
NM_001406894.1:c.-77T>G
NM_001406895.1:c.-77T>G
NM_001406896.1:c.-52-1131T>G
NM_001406897.1:c.-130T>G
NM_001406898.1:c.-130T>G
NM_001406899.1:c.-77T>G
NM_001406900.1:c.-132+205T>G
NM_001406901.1:c.35+205T>G
NM_001406902.1:c.35+205T>G
NM_001406903.1:c.35+205T>G
NM_001406904.1:c.-77T>G
NM_001406905.1:c.-130T>G
NM_001406906.1:c.-130T>G
NM_001406907.1:c.-77T>G
NM_001406908.1:c.-130T>G
NM_001406909.1:c.-77T>G
NM_001406910.1:c.-130T>G
NM_001406911.1:c.-130T>G
NM_001406912.1:c.276T>G
NP_000526.1:p.Ile92Met
NP_000526.2:p.Ile92Met
NP_001308935.1:p.Ile92Met
NP_001308943.1:p.Ile92Met
NP_001393795.1:p.Ile154Met
NP_001393797.1:p.Ile100Met
NP_001393798.1:p.Ile92Met
NP_001393799.1:p.Ile92Met
NP_001393800.1:p.Ile92Met
NP_001393801.1:p.Ile92Met
NP_001393802.1:p.Ile92Met
NP_001393803.1:p.Ile92Met
NP_001393813.1:p.Ile92Met
NP_001393815.1:p.Ile92Met
NP_001393841.1:p.Ile92Met
LRG_161t1:c.276T>G
LRG_161:g.10340T>G
LRG_161p1:p.Ile92Met
NC_000007.13:g.6043398A>C
NM_000535.5:c.276T>G
NR_003085.2:n.358T>G
NR_136154.1:n.363T>G

Protein change:

I100M

Molecular consequence:

NM_001322003.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322004.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322005.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322009.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322010.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322011.2:c.-609T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322012.2:c.-609T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322013.2:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322015.2:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406875.1:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406877.1:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406878.1:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406879.1:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406880.1:c.-156T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406882.1:c.-209T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406887.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406888.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406889.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406890.1:c.-120T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406891.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406892.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406893.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406894.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406895.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406897.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406898.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406899.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406904.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406905.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406906.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406907.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406908.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406909.1:c.-77T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406910.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001406911.1:c.-130T>G - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001322007.2:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001322008.2:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406876.1:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406881.1:c.-132+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406883.1:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406885.1:c.250+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406896.1:c.-52-1131T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406900.1:c.-132+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406901.1:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406902.1:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_001406903.1:c.35+205T>G - intron variant - [Sequence Ontology: SO:0001627]
NM_000535.7:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001322006.2:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001322014.2:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406866.1:c.462T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406868.1:c.300T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406869.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406870.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406871.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406872.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406873.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406874.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406884.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406886.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NM_001406912.1:c.276T>G - missense variant - [Sequence Ontology: SO:0001583]
NR_136154.1:n.363T>G - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:: Hereditary nonpolyposis colorectal neoplasms
Identifiers:: MeSH: D003123; MedGen: C0009405

Recent activity

Clear Turn Off Turn On

Exophiala oligosperma uncharacterized protein (PV06_10220), partial mRNA
Exophiala oligosperma uncharacterized protein (PV06_10220), partial mRNA
gi|1022901852|ref|XM_016411749.1|

Nucleotide
Exophiala oligosperma hypothetical protein, variant (PV06_10252), mRNA
Exophiala oligosperma hypothetical protein, variant (PV06_10252), mRNA
gi|1022901996|ref|XM_016411785.1|

Nucleotide
Exophiala oligosperma uncharacterized protein (PV06_10239), partial mRNA
Exophiala oligosperma uncharacterized protein (PV06_10239), partial mRNA
gi|1022901940|ref|XM_016411771.1|

Nucleotide

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004410204	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Nov 10, 2022)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004410204

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Nov 10, 2022)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004410204.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt PMS2 protein function. This variant has not been reported in the literature in individuals affected with PMS2-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 92 of the PMS2 protein (p.Ile92Met). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine